SEARCH RESULTS FOR: ("Imitation The Queen")(3979261 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Temporary hip spacer with gentamicin. InterSpace Hip is composed of fully formed gentamicin/polymethylmethacrylate (PMMA) radiopaque bone cement coated onto a stainless steel reinforcing structure. The device is sterile and single-use. InterSpace Hip is indicated for temporary use (maximum of 180 days) as a total hip replacement (THR) in skeletally mature patients undergoing a two-stage procedure due to a septic process. The device is inserted into the femoral medullary canal and acetabular cavity following removal of the existing implant and radical debridement. The device is intended for use in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach to an infection). InterSpace Hip is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g., resection arthroplasty, fusion, etc.).
TECRES SPA
SPC0322
In Commercial Distribution

  • 28031497000644 ()

  • Length: 211 Millimeter
  • dimater of the femoral head: 46 mm


  • Orthopaedic cement spacer
Temporary hip spacer with gentamicin. InterSpace Hip is composed of fully formed gentamicin/polymethylmethacrylate (PMMA) radiopaque bone cement coated onto a stainless steel reinforcing structure. The device is sterile and single-use. InterSpace Hip is indicated for temporary use (maximum of 180 days) as a total hip replacement (THR) in skeletally mature patients undergoing a two-stage procedure due to a septic process. The device is inserted into the femoral medullary canal and acetabular cavity following removal of the existing implant and radical debridement. The device is intended for use in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach to an infection). InterSpace Hip is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g., resection arthroplasty, fusion, etc.).
TECRES SPA
SPC0122
In Commercial Distribution

  • 28031497000620 ()

  • Length: 94 Millimeter
  • diameter of the femoral head: 54 mm


  • Orthopaedic cement spacer
Temporary hip spacer with gentamicin. InterSpace Hip is composed of fully formed gentamicin/polymethylmethacrylate (PMMA) radiopaque bone cement coated onto a stainless steel reinforcing structure. The device is sterile and single-use. InterSpace Hip is indicated for temporary use (maximum of 180 days) as a total hip replacement (THR) in skeletally mature patients undergoing a two-stage procedure due to a septic process. The device is inserted into the femoral medullary canal and acetabular cavity following removal of the existing implant and radical debridement. The device is intended for use in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach to an infection). InterSpace Hip is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g., resection arthroplasty, fusion, etc.).
TECRES SPA
SPC0022
In Commercial Distribution

  • 28031497000613 ()

  • Length: 96 Millimeter
  • diameter of the femoral head 46 mm


  • Orthopaedic cement spacer
Temporary hip spacer with gentamicin. InterSpace Hip is composed of fully formed gentamicin/polymethylmethacrylate (PMMA) radiopaque bone cement coated onto a stainless steel reinforcing structure. The device is sterile and single-use. InterSpace Hip is indicated for temporary use (maximum of 180 days) as a total hip replacement (THR) in skeletally mature patients undergoing a two-stage procedure due to a septic process. The device is inserted into the femoral medullary canal and acetabular cavity following removal of the existing implant and radical debridement. The device is intended for use in conjunction with systemic antimicrobial antibiotic therapy (standard treatment approach to an infection). InterSpace Hip is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g., resection arthroplasty, fusion, etc.).
TECRES SPA
SPC0222
In Commercial Distribution

  • 28031497000637 ()

  • Length: 98 Millimeter
  • diameter of the femoral head: 60 mm


  • Orthopaedic cement spacer
Rapid Response Multi Drug Test Panel (COC/AMP/MET/THC/OPI/MDMA) - 25 tests/ kit are for qualitative detection of Amphetamine, Methamphetamine, Opiates, 3,4-Methyoxydiene-Methamphetamine, Cocaine and THC metabolites in urine.
BTNX Inc
D6.14-1P29-25
In Commercial Distribution

  • 00722066003459 ()
  • 00722066004012 ()
D6.14-1P29-25

  • Multiple drugs of abuse IVD, kit, rapid ICT, clinical
COC, OPI300, AMP, MET, BZO, OXY with Adulteration Screen for OX/SG/PH
AMEDITECH INC.
C-C0611A-3A
Not in Commercial Distribution

  • 00816565020540 ()
C-C0611A-3A

  • Multiple drugs of abuse IVD, kit, rapid ICT, clinical
THC, COC, OPI, AMP, MET with Adulteration Screen for OX/SG/PH
AMEDITECH INC.
C-C0503A-3A
Not in Commercial Distribution

  • 00816565020526 ()
C-C0503A-3A

  • Multiple drugs of abuse IVD, kit, rapid ICT, clinical
THC, COC, OPI, AMP, MET with Adulteration Screen for OX/SG/PH
BRANAN MEDICAL CORPORATION
C-C0503A-3A
Not in Commercial Distribution

  • 00816555020291 ()
C-C0503A-3A

  • Multiple drugs of abuse IVD, kit, rapid ICT, clinical
COC, OPI300, AMP, MET, OXY, BZO with Adulteration Screen for OX/SG/PH
BRANAN MEDICAL CORPORATION
C-C0611A-3A
Not in Commercial Distribution

  • 00816555020277 ()
C-C0611A-3A

  • Multiple drugs of abuse IVD, kit, rapid ICT, clinical
Provides the connection between the Garment and the Monitor
Kestra Medical Technologies, Inc.
80004-003
In Commercial Distribution

  • 00840241600023 ()
80004-003

  • Wearable defibrillation system defibrillator
< 1 ... 656 657 658 659 660 ... 1000 >